BlackRock Health Sciences Trust (BME) - Net Assets
Based on the latest financial reports, BlackRock Health Sciences Trust (BME) has net assets worth $568.30 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($570.14 Million) and total liabilities ($1.83 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BME asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $568.30 Million |
| % of Total Assets | 99.68% |
| Annual Growth Rate | 5.43% |
| 5-Year Change | -9.18% |
| 10-Year Change | 109.94% |
| Growth Volatility | 90.95 |
BlackRock Health Sciences Trust - Net Assets Trend (2006–2025)
This chart illustrates how BlackRock Health Sciences Trust's net assets have evolved over time, based on quarterly financial data. Also explore total assets of BlackRock Health Sciences Trust for the complete picture of this company's asset base.
Annual Net Assets for BlackRock Health Sciences Trust (2006–2025)
The table below shows the annual net assets of BlackRock Health Sciences Trust from 2006 to 2025. For live valuation and market cap data, see BlackRock Health Sciences Trust (BME) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $568.30 Million | -26.06% |
| 2024-12-31 | $768.57 Million | +30.68% |
| 2023-12-31 | $588.14 Million | -2.01% |
| 2022-12-31 | $600.20 Million | -4.09% |
| 2021-12-31 | $625.77 Million | +14.62% |
| 2020-12-31 | $545.94 Million | -66.63% |
| 2019-12-31 | $1.64 Billion | +363.87% |
| 2018-12-31 | $352.67 Million | +6.27% |
| 2017-12-31 | $331.86 Million | +22.60% |
| 2016-12-31 | $270.69 Million | -9.02% |
| 2015-12-31 | $297.53 Million | -1.84% |
| 2014-12-31 | $303.10 Million | +12.19% |
| 2013-12-31 | $270.16 Million | +23.71% |
| 2012-12-31 | $218.38 Million | +21.56% |
| 2008-12-31 | $179.64 Million | -21.99% |
| 2007-12-31 | $230.28 Million | +10.63% |
| 2006-12-31 | $208.15 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to BlackRock Health Sciences Trust's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 617.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $210.69 Million | 37.07% |
| Common Stock | $357.61 Million | 62.93% |
| Other Comprehensive Income | $210.69 Million | 37.07% |
| Total Equity | $568.30 Million | 100.00% |
BlackRock Health Sciences Trust Competitors by Market Cap
The table below lists competitors of BlackRock Health Sciences Trust ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hubei Shuanghuan Science and Technology Stock Co Ltd
SHE:000707
|
$509.10 Million |
|
SEALSQ Corp
NASDAQ:LAES
|
$509.14 Million |
|
Duniec
TA:DUNI
|
$509.28 Million |
|
PT Estee Gold Feet Tbk
JK:EURO
|
$509.29 Million |
|
Shanghai Conglin Environmental Protection Technology Co. Ltd. A
SHG:688370
|
$508.80 Million |
|
Hanssem
KO:009240
|
$508.49 Million |
|
F&F Holdings Co. Ltd
KO:007700
|
$508.36 Million |
|
Perfect Group Corp Ltd Class A
SHG:603059
|
$508.28 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BlackRock Health Sciences Trust's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 768,567,015 to 568,304,240, a change of -200,262,775 (-26.1%).
- Net income of 76,969,217 contributed positively to equity growth.
- Dividend payments of 40,610,643 reduced retained earnings.
- Share repurchases of 13,977,639 reduced equity.
- Other comprehensive income increased equity by 210,691,745.
- Other factors decreased equity by 433,335,455.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $76.97 Million | +13.54% |
| Dividends Paid | $40.61 Million | -7.15% |
| Share Repurchases | $13.98 Million | -2.46% |
| Other Comprehensive Income | $210.69 Million | +37.07% |
| Other Changes | $-433.34 Million | -76.25% |
| Total Change | $- | -26.06% |
Book Value vs Market Value Analysis
This analysis compares BlackRock Health Sciences Trust's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.90x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.39x to 0.90x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $28.34 | $39.39 | x |
| 2013-12-31 | $34.92 | $39.39 | x |
| 2014-12-31 | $38.84 | $39.39 | x |
| 2015-12-31 | $36.19 | $39.39 | x |
| 2016-12-31 | $31.30 | $39.39 | x |
| 2017-12-31 | $37.34 | $39.39 | x |
| 2018-12-31 | $40.55 | $39.39 | x |
| 2019-12-31 | $14.52 | $39.39 | x |
| 2020-12-31 | $26.83 | $39.39 | x |
| 2021-12-31 | $5.54 | $39.39 | x |
| 2022-12-31 | $47.61 | $39.39 | x |
| 2023-12-31 | $42.18 | $39.39 | x |
| 2024-12-31 | $57.98 | $39.39 | x |
| 2025-12-31 | $43.71 | $39.39 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BlackRock Health Sciences Trust utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.54%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 212.86%
- • Asset Turnover: 0.06x
- • Equity Multiplier: 1.00x
- Recent ROE (13.54%) is above the historical average (7.50%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 11.81% | 91.20% | 0.12x | 1.04x | $3.76 Million |
| 2007 | 15.90% | 93.81% | 0.16x | 1.03x | $13.58 Million |
| 2008 | -19.43% | -240.81% | 0.08x | 1.05x | $-52.87 Million |
| 2012 | 14.72% | 1081.14% | 0.01x | 1.04x | $10.31 Million |
| 2013 | 25.67% | 1907.49% | 0.01x | 1.01x | $42.33 Million |
| 2014 | 16.61% | 1580.65% | 0.01x | 1.01x | $20.04 Million |
| 2015 | 11.18% | 60.60% | 0.18x | 1.01x | $3.52 Million |
| 2016 | -6.01% | -63.00% | 0.09x | 1.01x | $-43.34 Million |
| 2017 | 18.18% | 99.35% | 0.18x | 1.01x | $27.15 Million |
| 2018 | 6.36% | 98.05% | 0.06x | 1.01x | $-12.83 Million |
| 2019 | 4.88% | 99.48% | 0.05x | 1.06x | $-83.72 Million |
| 2020 | 2.63% | 99.34% | 0.14x | 0.18x | $-222.81 Million |
| 2021 | 9.45% | 99.09% | 0.09x | 1.04x | $-3.46 Million |
| 2022 | -4.41% | 0.00% | -0.04x | 1.01x | $-86.49 Million |
| 2023 | 3.40% | 57.36% | 0.06x | 1.01x | $-38.80 Million |
| 2024 | 3.05% | 97.44% | 0.03x | 1.01x | $-53.40 Million |
| 2025 | 13.54% | 212.86% | 0.06x | 1.00x | $20.14 Million |
Industry Comparison
This section compares BlackRock Health Sciences Trust's net assets metrics with peer companies in the Asset Management industry.
Industry Context
- Industry: Asset Management
- Average net assets among peers: $1,222,611,667
- Average return on equity (ROE) among peers: 5.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BlackRock Health Sciences Trust (BME) | $568.30 Million | 11.81% | 0.00x | $509.08 Million |
| Acadian Asset Management Inc (AAMI) | $84.00 Million | 95.24% | 7.06x | $1.86 Billion |
| AllianceBernstein Holding L.P. (AB) | $2.07 Billion | 13.23% | 0.00x | $3.60 Billion |
| Associated Capital Group Inc (AC) | $948.70 Million | 4.12% | 0.07x | $78.56 Million |
| Abrdn Emerging Markets Equity Income Fund Inc (AEF) | $79.50 Million | 27.37% | 0.59x | $265.69 Million |
| AgriFORCE Growing Systems Ltd (AGRI) | $2.99 Million | -170.94% | 0.46x | $194.14 Million |
| Alvarium Tiedemann Holdings Inc. (ALTI) | $782.49 Million | -21.16% | 0.62x | $368.87 Million |
| Affiliated Managers Group Inc (AMG) | $962.54 Million | 12.37% | 1.41x | $8.19 Billion |
| Ameriprise Financial Inc (AMP) | $6.55 Billion | 54.41% | 28.15x | $41.87 Billion |
| AMTD IDEA Group (AMTD) | $611.58 Million | 16.58% | 4.02x | $44.19 Million |
| Artisan Partners Asset Management Inc (APAM) | $132.30 Million | 18.75% | 3.39x | $2.65 Billion |
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or d… Read more